|
n = 309 (FC = 101, SF = 82, LC = 126)
|
Mean ± SD
|
---|
Age (years)
|
FC
|
62.9 ± 12.8
|
SF
|
63.6 ± 13.3
|
LC
|
61.7 ± 11.4
|
Total
|
62.6 ± 12.4
|
BMI (kg/m2)
|
FC
|
23.1 ± 4.4
|
SF
|
22.7 ± 4.6
|
LC
|
23.7 ± 3.8
|
Total
|
23.2 ± 4.2
|
HD duration (months)
|
FC
|
59.5 ± 55.0
|
SF
|
70.6 ± 78.9
|
LC
|
71.4 ± 54.9
|
Total
|
67.3 ± 62.1
|
Hb g/dL
|
FC
|
10.7 ± 1.0
|
SF
|
11.0 ± 1.2
|
LC
|
10.9 ± 0.9
|
Total
|
10.9 ± 1.0
|
Pi mg/dL
|
FC
|
6.172 ± 1.6339
|
SF
|
6.216 ± 1.2109
|
LC
|
5.948 ± 1.4938
|
Total
|
6.093 ± 1.4726
|
Gender
| |
F
|
M
|
FC
|
27.7%
|
72.3%
|
SF
|
37.8%
|
62.2%
|
LC
|
27.0%
|
73.0%
|
DM/non-DM
| |
Non-DM
|
DM
|
FC
|
68.3%
|
31.7%
|
SF
|
62.2%
|
37.8%
|
LC
|
57.1%
|
42.9%
|
Combined drug
|
FC
|
65/101
|
64.4%
|
SF
|
57/82
|
69.5%
|
LC
|
54/126
|
42.9%
|
Total
|
176/311
|
57.0%
|
- Combined drug: includes sevelamer and a Ca-containing drug
-
DM diabetes mellitus, BMI body mass index, HD hemodialysis